PROM1 and neoplasm: On the other hand, after treatment with anlotinib, the expression level of stemness‐associated markers, ALDH1 and CD133, was obviously reduced in PC‐9‐ and HCC827‐derived LCSCs as well as the xenografts of PC‐9‐derived LCSC tumour‐bearing mice.